Renal Cancer - Results from #60

GLYAT suppresses liver cancer and clear cell renal cell carcinoma progression by downregulating ROCK1 expression. October 24, 2024

Cytoreductive Nephrectomy Following Immunotherapy for Metastatic Renal Cell Carcinoma and IVC Tumor Thrombus Arising from a Horseshoe Kidney. October 23, 2024

Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors. October 23, 2024

Prognosis and progression of phagocytic regulatory factor-related gene combinations in clear cell renal cell carcinoma (ccRCC). October 22, 2024

A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy. October 22, 2024

TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum. October 21, 2024

Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration. October 21, 2024

Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study. October 18, 2024

Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study. October 18, 2024

Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings. October 17, 2024

Cost-effectiveness of pembrolizumab as an adjuvant treatment of renal cell carcinoma post-nephrectomy in Switzerland. October 17, 2024

Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. October 17, 2024

Dense Collagen I as a Biomimetic Material to Track Matrix Remodelling in Renal Carcinomas. October 16, 2024

Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma. October 16, 2024

Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort. October 15, 2024

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the novel NAMPT Inhibitor OT-82. October 15, 2024

The Influence of Pre-ablation Embolization Particle Size on the Size of the Microwave Ablation Zone in a Porcine Orthotopic Renal Tumor Model. October 14, 2024

Predicting post-surgical complications using renal scoring systems. October 14, 2024

Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: analysis of a UK-based population. October 11, 2024

Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma. October 11, 2024

Page 4 of 455